☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
ImmunityBio
ImmunityBio Reports P-II/III (QUILT 3.032) Trial Results of N-803 + BCG for the Treatment of Bladder Cancer
November 11, 2022
Load more...
Back to Home